ELEVATION ONCOLOGY
Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Its lead candidate, seribantumab, which inhibits tumor growth driven by NRG1 fusions, is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion.
ELEVATION ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.elevationoncology.com
Total Employee:
11+
Status:
Active
Contact:
(716) 371-1125
Email Addresses:
[email protected]
Total Funding:
147.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Elevation Oncology
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Elevation Oncology
venBio Partners
venBio Partners investment in Series B - Elevation Oncology
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Elevation Oncology
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Elevation Oncology
Aisling Capital
Aisling Capital investment in Series B - Elevation Oncology
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Elevation Oncology
Samsara BioCapital
Samsara BioCapital investment in Series B - Elevation Oncology
BVF Partners
BVF Partners investment in Series B - Elevation Oncology
Vivo Capital
Vivo Capital investment in Series B - Elevation Oncology
Key Employee Changes
Official Site Inspections
http://www.elevationoncology.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.87 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
